University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...

Better cancer care depends on better treatment options. That's why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next ...

Researchers from the Indiana University Melvin and Bren Simon Comprehensive Cancer Center are part of an international team ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

TAIPEI, March 5, 2026 /PRNewswire/ -- Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator ...

The discovery of new medicines often takes place in North America, Europe and Asia. So that's where the agenda tends to be ...

Early trials, according to The New York Times, have shown that people with obesity and knee osteoarthritis lost 28.7 percent of their body weight after taking the highest dose for nearly 70 weeks, ...

A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...

Researchers at Boston University’s Structural Bioinformatics Lab are working with Mercury Computer Systems to develop a system that will make it easier for pharmaceutical companies to develop new ...

(Bloomberg) -- Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding its portfolio of oncology treatments. Based in the UK, ...

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience. "It doesn't mean that there aren't surprises or miracles," he says. "They do ...